Provided By PR Newswire
Last update: Nov 7, 2024
Third Quarter Highlights:
ATLANTA, Nov. 7, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the third quarter ended September 30, 2024.
Read more at prnewswire.com